Annual D&A
$1.24 M
+$240.00 K+24.05%
31 December 2023
Summary:
Rigel Pharmaceuticals annual depreciation & amortization is currently $1.24 million, with the most recent change of +$240.00 thousand (+24.05%) on 31 December 2023. During the last 3 years, it has risen by +$532.00 thousand (+75.35%). RIGL annual D&A is now -83.62% below its all-time high of $7.56 million, reached on 31 December 2000.RIGL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$611.00 K
-$2000.00-0.33%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly depreciation & amortization is currently $611.00 thousand, with the most recent change of -$2000.00 (-0.33%) on 30 September 2024. Over the past year, it has increased by +$319.00 thousand (+109.25%). RIGL quarterly D&A is now -67.94% below its all-time high of $1.91 million, reached on 31 March 2001.RIGL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.92 M
+$319.00 K+19.96%
30 September 2024
Summary:
Rigel Pharmaceuticals TTM depreciation & amortization is currently $1.92 million, with the most recent change of +$319.00 thousand (+19.96%) on 30 September 2024. Over the past year, it has increased by +$688.00 thousand (+55.98%). RIGL TTM D&A is now -71.64% below its all-time high of $6.76 million, reached on 31 December 2001.RIGL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.1% | +109.3% | +56.0% |
| 3 y3 years | +75.3% | +134.1% | +98.9% |
| 5 y5 years | +108.4% | +268.1% | +187.8% |
RIGL Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +75.3% | -0.3% | +157.8% | at high | +98.9% |
| 5 y | 5 years | at high | +108.4% | -0.3% | +272.6% | at high | +187.8% |
| alltime | all time | -83.6% | +166.2% | -67.9% | +445.5% | -71.6% | +324.1% |
Rigel Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $611.00 K(-0.3%) | $1.92 M(+20.0%) |
| June 2024 | - | $613.00 K(+53.3%) | $1.60 M(+24.7%) |
| Mar 2024 | - | $400.00 K(+36.5%) | $1.28 M(+3.5%) |
| Dec 2023 | $1.24 M(+24.0%) | $293.00 K(+0.3%) | $1.24 M(+0.7%) |
| Sept 2023 | - | $292.00 K(-1.4%) | $1.23 M(+4.4%) |
| June 2023 | - | $296.00 K(-17.1%) | $1.18 M(+5.3%) |
| Mar 2023 | - | $357.00 K(+25.7%) | $1.12 M(+12.0%) |
| Dec 2022 | $998.00 K(-14.1%) | $284.00 K(+18.3%) | $998.00 K(-10.7%) |
| Sept 2022 | - | $240.00 K(+1.3%) | $1.12 M(-1.8%) |
| June 2022 | - | $237.00 K(0.0%) | $1.14 M(-1.8%) |
| Mar 2022 | - | $237.00 K(-41.3%) | $1.16 M(-0.2%) |
| Dec 2021 | $1.16 M(+64.6%) | $404.00 K(+54.8%) | $1.16 M(+20.5%) |
| Sept 2021 | - | $261.00 K(+1.2%) | $964.00 K(+11.1%) |
| June 2021 | - | $258.00 K(+7.9%) | $868.00 K(+12.1%) |
| Mar 2021 | - | $239.00 K(+16.0%) | $774.00 K(+9.6%) |
| Dec 2020 | $706.00 K(+3.4%) | $206.00 K(+24.8%) | $706.00 K(+3.8%) |
| Sept 2020 | - | $165.00 K(+0.6%) | $680.00 K(-0.1%) |
| June 2020 | - | $164.00 K(-4.1%) | $681.00 K(-1.3%) |
| Mar 2020 | - | $171.00 K(-5.0%) | $690.00 K(+1.0%) |
| Dec 2019 | $683.00 K(+15.0%) | $180.00 K(+8.4%) | $683.00 K(+2.6%) |
| Sept 2019 | - | $166.00 K(-4.0%) | $666.00 K(+1.1%) |
| June 2019 | - | $173.00 K(+5.5%) | $659.00 K(+2.2%) |
| Mar 2019 | - | $164.00 K(+0.6%) | $645.00 K(+8.6%) |
| Dec 2018 | $594.00 K(+27.7%) | $163.00 K(+2.5%) | $594.00 K(+9.2%) |
| Sept 2018 | - | $159.00 K(0.0%) | $544.00 K(+9.5%) |
| June 2018 | - | $159.00 K(+40.7%) | $497.00 K(+10.0%) |
| Mar 2018 | - | $113.00 K(0.0%) | $452.00 K(-2.8%) |
| Dec 2017 | $465.00 K(-50.6%) | $113.00 K(+0.9%) | $465.00 K(-6.1%) |
| Sept 2017 | - | $112.00 K(-1.8%) | $495.00 K(-17.1%) |
| June 2017 | - | $114.00 K(-9.5%) | $597.00 K(-19.7%) |
| Mar 2017 | - | $126.00 K(-11.9%) | $743.00 K(-21.0%) |
| Dec 2016 | $941.00 K(-34.6%) | $143.00 K(-33.2%) | $941.00 K(-17.2%) |
| Sept 2016 | - | $214.00 K(-17.7%) | $1.14 M(-6.0%) |
| June 2016 | - | $260.00 K(-19.8%) | $1.21 M(-9.0%) |
| Mar 2016 | - | $324.00 K(-4.1%) | $1.33 M(-7.7%) |
| Dec 2015 | $1.44 M(-39.0%) | $338.00 K(+17.8%) | $1.44 M(-10.5%) |
| Sept 2015 | - | $287.00 K(-24.3%) | $1.61 M(-15.1%) |
| June 2015 | - | $379.00 K(-12.9%) | $1.90 M(-11.4%) |
| Mar 2015 | - | $435.00 K(-14.2%) | $2.14 M(-9.3%) |
| Dec 2014 | $2.36 M(-9.0%) | $507.00 K(-11.7%) | $2.36 M(-5.8%) |
| Sept 2014 | - | $574.00 K(-7.9%) | $2.50 M(-2.7%) |
| June 2014 | - | $623.00 K(-4.9%) | $2.57 M(-0.2%) |
| Mar 2014 | - | $655.00 K(+0.6%) | $2.58 M(-0.5%) |
| Dec 2013 | $2.59 M(+6.5%) | $651.00 K(+1.1%) | $2.59 M(+0.6%) |
| Sept 2013 | - | $644.00 K(+2.5%) | $2.58 M(+0.4%) |
| June 2013 | - | $628.00 K(-6.1%) | $2.57 M(+0.7%) |
| Mar 2013 | - | $669.00 K(+5.2%) | $2.55 M(+4.8%) |
| Dec 2012 | $2.43 M | $636.00 K(+0.2%) | $2.43 M(+4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | $635.00 K(+4.1%) | $2.32 M(+5.9%) |
| June 2012 | - | $610.00 K(+10.5%) | $2.19 M(+6.5%) |
| Mar 2012 | - | $552.00 K(+4.9%) | $2.06 M(+5.4%) |
| Dec 2011 | $1.96 M(+48.4%) | $526.00 K(+4.0%) | $1.96 M(+7.3%) |
| Sept 2011 | - | $506.00 K(+6.3%) | $1.82 M(+10.9%) |
| June 2011 | - | $476.00 K(+6.5%) | $1.64 M(+12.6%) |
| Mar 2011 | - | $447.00 K(+13.7%) | $1.46 M(+10.8%) |
| Dec 2010 | $1.32 M(-6.1%) | $393.00 K(+20.2%) | $1.32 M(+3.7%) |
| Sept 2010 | - | $327.00 K(+12.0%) | $1.27 M(-2.9%) |
| June 2010 | - | $292.00 K(-4.3%) | $1.31 M(-5.8%) |
| Mar 2010 | - | $305.00 K(-11.8%) | $1.39 M(-1.1%) |
| Dec 2009 | $1.40 M(-1.5%) | $346.00 K(-5.2%) | $1.40 M(-1.1%) |
| Sept 2009 | - | $365.00 K(-1.9%) | $1.42 M(+0.8%) |
| June 2009 | - | $372.00 K(+16.3%) | $1.41 M(+0.3%) |
| Mar 2009 | - | $320.00 K(-11.4%) | $1.40 M(-1.5%) |
| Dec 2008 | $1.43 M(+6.0%) | $361.00 K(+2.0%) | $1.43 M(+1.9%) |
| Sept 2008 | - | $354.00 K(-3.8%) | $1.40 M(+1.4%) |
| June 2008 | - | $368.00 K(+7.6%) | $1.38 M(+2.2%) |
| Mar 2008 | - | $342.00 K(+2.1%) | $1.35 M(+0.4%) |
| Dec 2007 | $1.34 M(-5.2%) | $335.00 K(0.0%) | $1.34 M(-6.5%) |
| Sept 2007 | - | $335.00 K(-0.9%) | $1.44 M(+0.7%) |
| June 2007 | - | $338.00 K(+0.6%) | $1.43 M(+0.6%) |
| Mar 2007 | - | $336.00 K(-21.7%) | $1.42 M(+0.1%) |
| Dec 2006 | $1.42 M(+20.2%) | $429.00 K(+32.0%) | $1.42 M(-3.5%) |
| Sept 2006 | - | $325.00 K(-1.5%) | $1.47 M(+16.9%) |
| June 2006 | - | $330.00 K(-1.2%) | $1.26 M(+4.5%) |
| Mar 2006 | - | $334.00 K(-30.4%) | $1.20 M(+1.9%) |
| Dec 2005 | $1.18 M(-50.3%) | $480.00 K(+324.8%) | $1.18 M(-16.8%) |
| Sept 2005 | - | $113.00 K(-59.1%) | $1.42 M(-21.0%) |
| June 2005 | - | $276.00 K(-11.3%) | $1.80 M(-12.7%) |
| Mar 2005 | - | $311.00 K(-56.7%) | $2.06 M(-13.3%) |
| Dec 2004 | $2.37 M(-25.3%) | $718.00 K(+46.2%) | $2.37 M(+2.9%) |
| Sept 2004 | - | $491.00 K(-8.6%) | $2.31 M(-8.3%) |
| June 2004 | - | $537.00 K(-14.4%) | $2.52 M(-10.2%) |
| Mar 2004 | - | $627.00 K(-3.8%) | $2.80 M(-11.8%) |
| Dec 2003 | $3.18 M(-45.4%) | $652.00 K(-6.7%) | $3.18 M(-18.6%) |
| Sept 2003 | - | $699.00 K(-15.1%) | $3.90 M(-12.6%) |
| June 2003 | - | $823.00 K(-17.9%) | $4.46 M(-12.6%) |
| Mar 2003 | - | $1.00 M(-27.1%) | $5.11 M(-12.3%) |
| Dec 2002 | $5.82 M(-13.8%) | $1.38 M(+9.1%) | $5.82 M(-5.8%) |
| Sept 2002 | - | $1.26 M(-13.9%) | $6.18 M(-5.7%) |
| June 2002 | - | $1.47 M(-14.9%) | $6.55 M(-0.3%) |
| Mar 2002 | - | $1.72 M(-0.6%) | $6.58 M(-2.7%) |
| Dec 2001 | $6.76 M(-10.5%) | $1.73 M(+6.1%) | $6.76 M(+34.5%) |
| Sept 2001 | - | $1.63 M(+9.9%) | $5.03 M(+48.2%) |
| June 2001 | - | $1.49 M(-22.0%) | $3.39 M(+78.0%) |
| Mar 2001 | - | $1.91 M | $1.91 M |
| Dec 2000 | $7.56 M(+296.5%) | - | - |
| Dec 1999 | $1.91 M | - | - |
FAQ
- What is Rigel Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual D&A year-on-year change?
- What is Rigel Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly D&A year-on-year change?
- What is Rigel Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals TTM D&A year-on-year change?
What is Rigel Pharmaceuticals annual depreciation & amortization?
The current annual D&A of RIGL is $1.24 M
What is the all time high annual D&A for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual depreciation & amortization is $7.56 M
What is Rigel Pharmaceuticals annual D&A year-on-year change?
Over the past year, RIGL annual depreciation & amortization has changed by +$240.00 K (+24.05%)
What is Rigel Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of RIGL is $611.00 K
What is the all time high quarterly D&A for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly depreciation & amortization is $1.91 M
What is Rigel Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, RIGL quarterly depreciation & amortization has changed by +$319.00 K (+109.25%)
What is Rigel Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of RIGL is $1.92 M
What is the all time high TTM D&A for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high TTM depreciation & amortization is $6.76 M
What is Rigel Pharmaceuticals TTM D&A year-on-year change?
Over the past year, RIGL TTM depreciation & amortization has changed by +$688.00 K (+55.98%)